Cancer Gene Therapy Week
Susan Hasty, Publisher
Table of Contents . . . February 10th, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Gene Therapy Week | Other Publications
Carcinoembryonic Antigen - Vaccine-based therapy demonstrates antitumor activity against intestinal tumors
Tumor Cells - Antiapoptotic factors such as p450 can enhance prodrug activation gene therapy
Glioblastoma - New human chromosome 22 genomic microarray identifies candidate tumor suppressor
Lung Cancer - Loss of pRb2/p130 expression can be associated with lower overall survival
Tumor Antigens - Dual-specific T cells combine proliferation and antitumor activity
Tumor Growth - CRE-decoy ODN may serve as target-based tool to treat cancer, other diseases
Bladder Cancer - The expression of RhoGDI2 inversely correlates with tumor progression
Brain Tumor - Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations
Breast Cancer - Mouse DAM1 regulates pro-apoptotic activity of BLK in mammary epithelial cells
Dendritic Cells - Culture method useful for expansion of progenitors, lentiviral gene transduction
Gastric Cancer - Genome-wide analysis in intestinal-type gastric cancers may predict metastases
Gastric Cancer - Ku70 and Ku80 expression may be related to cell proliferation/ carcinogenesis
Genetics - Resveratrol may have genotoxic/hormonal activity in humans
Genomics - Deregulation of translation is associated with a wide range of cancers
Genomics - The Caudal homeodomain protein activates Drosophila E2F gene expression
Hepatic Cancer - Isolated liver perfusion offers advantages for chemotherapy/biotherapy
Hereditary Periodic-Fever Syndromes - Gene mutations may lead to leukocyte survival, prolonged inflammatory response
Human Cancer - DNA damage checkpoint pathway may be linked to high frequency of p53 mutations
Neurofibromatosis 2 Gene - Schwannomin requires HRS interaction to inhibit STAT activation
Oncology - Cdc25 inhibitor could contribute to cell cycle progression
Prostate Cancer - HEPSIN inhibits cell growth/invasion in prostate cancer cells
Prostate Cancer - Plasmid vector sensitizes cells to DNA-damaging treatments
Transitional Cell Cancer - XIAP may be candidate as cancer therapy for overcoming drug resistance
Urologic Cancer - RNASEL Arg462Gln variant implicated in up to 13% of prostate cancer cases
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
